Search

Search Results

• IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma

  Hongfeng Wang, Jianbin Chen

  e2026062

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.062

  145

  PDF: 482

  HTML: 45

• Immune thrombocytopenic purpura cases following COVID-19 vaccination.

  Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida

  e2021047

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.047

  1163

  PDF: 461

  HTML: 334

• ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

  Soner Solmaz

  e2016019

  2016-03-01

  https://doi.org/10.4084/mjhid.2016.019

  3089

  PDF: 1000

  HTML: 1588

• PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.

  Dilip Kumar Patel, Manoj Kumar Mohapatra, Ancil George Thomas, Siris Patel, Prasanta Purohit

  e2014018

  2014-02-16

  https://doi.org/10.4084/mjhid.2014.018

  2124

  PDF: 1076

  HTML: 15732

  COVER LETTER: 205

• Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

  Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain

  e2010012

  2010-05-31

  https://doi.org/10.4084/mjhid.2010.012

  1087

  PDF: 709

  HTML: 376

• SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

  Massimo Breccia, Giuliana Alimena

  e2014003

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.003

  3341

  PDF: 1246

  HTML: 3522

• SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

  Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini

  e2021046

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.046

  1467

  PDF: 771

  HTML: 438

• TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

  Agustin Avilès, Maria-Jesus Nambo, Natividad Neri

  e2018006

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.006

  3897

  PDF: 1111

  HTML: 904

• VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

  Ashraf Tawfik Soliman

  e2013057

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.057

  2802

  PDF: 1110

  HTML: 2594

• LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

  Fabian Herrera

  e2024039

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.039

  1485

  PDF: 1045

  HTML: 128

• Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia

  Jérôme Guison, Gilles Blaison, Oana Stoica, Remy Hurstel, Marie Favier, Remi Favier

  e2017038

  2017-06-16

  https://doi.org/10.4084/mjhid.2017.038

  2295

  PDF: 858

  HTML: 964

  Patient’s family tree: 192